Veterinary Autoimmune Disease Therapeutics Global Market Report 2025

Description

Veterinary autoimmune disease therapeutics encompass treatments tailored to manage and alleviate animal autoimmune conditions. These therapies are geared towards modulating or suppressing the immune response to mitigate inflammation, halt further tissue damage, and enhance the overall well-being and quality of life of affected animals. Given the complexity of these conditions, veterinary autoimmune disease therapeutics necessitate a customized approach, taking into account the specific disease, its severity, and the individual needs of the animal.

The primary types of therapy within veterinary autoimmune disease therapeutics include corticosteroids, azathioprine, cyclosporine, mycophenolate, leflunomide, cyclophosphamide, levothyroxine, folic acid, hydroxychloroquine, and chloroquine. Corticosteroids, derived from steroid hormones produced in the adrenal cortex, are commonly utilized in medicine to diminish inflammation and suppress immune activity. They are administered to various animals, including companion and livestock animals, to address conditions such as disease-type hypothyroidism, pemphigus disease, canine lupus, autoimmune hemolytic anemia, bullous pemphigoid, discoid lupus erythematosus (DLE), immune-related arthritis, among others. These therapeutic agents are typically dispensed through veterinary hospitals and clinics.

The veterinary autoimmune disease therapeutics research report is one of a series of new reports from The Business Research Company that provides veterinary autoimmune disease therapeutics market statistics, including the veterinary autoimmune disease therapeutics industry's global market size, regional shares, competitors with a veterinary autoimmune disease therapeutics market share, detailed veterinary autoimmune disease therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary autoimmune disease therapeutics industry. This veterinary autoimmune disease therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The veterinary autoimmune disease therapeutics market size has grown strongly in recent years. It will grow from $3.25 billion in 2024 to $3.47 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to advances in immunology, increased pet ownership, improved diagnostic methods, development of new drug classes, and rising awareness of pet health.

The veterinary autoimmune disease therapeutics market size is expected to see strong growth in the next few years. It will grow to $4.48 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to advancements in biotechnology, growing investment in veterinary healthcare, increasing prevalence of autoimmune diseases in pets, development of novel therapeutics, and rising pet insurance adoption. Major trends in the forecast period include personalized medicine, the use of biologics, the integration of telemedicine, adoption of regenerative therapies, and focus on holistic and integrative treatments personalized medicine, use of biologics, integration of telemedicine, adoption of regenerative therapies, and focus on holistic and integrative treatments.

The increased funding for research in veterinary medicine is anticipated to drive the growth of the veterinary autoimmune disease therapeutics market in the coming years. Veterinary medicine, which focuses on preventing, diagnosing, and treating diseases, disorders, and injuries in animals, is receiving more funding due to various factors such as rising zoonotic diseases, the expanding pet industry, technological advancements in animal health, agricultural needs, and wildlife conservation efforts. This increased funding supports research on veterinary autoimmune diseases, including studies on disease mechanisms, diagnostic tools, and treatment options, thereby enhancing the ability to diagnose and manage these conditions effectively. For example, the National Institute of Food and Agriculture announced the Veterinary Service Grants Program in August 2024, investing $3.2 million in rural food animal veterinary medicine in the fiscal year 2022 across the United States. Hence, the heightened research funding in veterinary medicine is propelling the growth of the veterinary autoimmune disease therapeutics market.

Major companies in the veterinary autoimmune disease therapeutics market are focusing on developing advanced technological solutions, such as RenBiologics, to meet key industry needs. RenBiologics specializes in creating innovative therapies for kidney-related conditions and chronic diseases, with a focus on biologics and regenerative medicine to improve outcomes in areas like renal function and transplant success. For example, in January 2024, Biocytogen, a China-based biotechnology company, launched a new sub-brand, RenBiologics, to focus on the out-licensing of fully human antibodies for therapeutic development. This initiative aims to leverage Biocytogen's extensive library of over 400,000 fully human antibody sequences, created using its proprietary RenMice platform. RenBiologics will support collaborations with pharmaceutical and biotechnology companies for co-development and licensing of these antibodies, advancing the potential for novel antibody-based therapeutics. The launch underscores Biocytogen's commitment to becoming a global leader in antibody discovery and accelerating the development of innovative treatments across multiple therapeutic areas.

In March 2024, AbbVie Inc., a US-based biopharmaceutical company specializing in medicines and solutions for complex health issues, acquired Landos Biopharma for $137.5 million. This acquisition enables AbbVie to expand its portfolio in inflammatory bowel diseases by advancing innovative therapies such as NX-13, addressing significant unmet needs in patient care. Landos Biopharma, also based in the US, focuses on developing autoimmune therapies, with potential applications for treating similar conditions in animals.

Major companies operating in the veterinary autoimmune disease therapeutics market are Pfizer Inc, Merck & Co Inc, AbbVie Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline, Takeda Pharmaceutical Company, Amgen Inc., Teva Pharmaceuticals Industries Ltd., Zoetis Inc, Boehringer Ingelheim International GmbH, Sumitomo Pharma Co. Ltd., IDEXX Laboratories Inc., Cipla Inc., Mallinckrodt Pharmaceuticals, Virbac S.A, Dechra Pharmaceuticals plc, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Heska Corporation, Bimeda Holdings PLC, Bayer Animal Health Inc, Aratana Therapeutics Inc, Hester Biosciences Limited

North America was the largest region in the veterinary autoimmune disease therapeutics market in 2024. The regions covered in the veterinary autoimmune disease therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary autoimmune disease therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary autoimmune disease therapeutics market consists of revenues earned by entities by providing immunosuppressive medications, biologic therapies, supportive therapies and complementary therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary autoimmune disease therapeutics market also includes sales of prednisone, mycophenolate mofetil, and methotrexate. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Autoimmune Disease Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary autoimmune disease therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary autoimmune disease therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary autoimmune disease therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Therapy Type: Corticosteroids; Azathioprine; Cyclosporine; Mycophenolate; Leflunomide; Cyclophosphamide; Levothyroxine; Folic Acid; Hydroxychloroquine; Chloroquine
2) By Animal Type: Companion Animals; Livestock Animals; Other Animals
3) By Disease: Hypothyroidism; Pemphigus Disease; Canine Lupus; Auto-Immune Hemolytic Anemia; Bullous Pemphigoid; Discoid Lupus Erythematosus (DLE); Immune-Related Arthritis; Other Diseases
4) By Distribution Channel: Veterinary Hospitals; Veterinary Clinics
Subsegments:
1) By Corticosteroids: Prednisone; Prednisolone; Dexamethasone; Methylprednisolone; Triamcinolone
2) By Azathioprine: Azathioprine Oral Tablets; Azathioprine Injectable Formulation
3) By Cyclosporine: Oral Cyclosporine (Atopica); Injectable Cyclosporine
4) By Mycophenolate: Mycophenolate Mofetil (Oral Form); Mycophenolate Sodium (Injectable Form)
5) By Leflunomide: Leflunomide Tablets (Oral); Leflunomide Injection
6) By Cyclophosphamide: Oral Cyclophosphamide; Injectable Cyclophosphamide
7) By Levothyroxine: Levothyroxine Sodium Tablets (Oral); Levothyroxine Sodium Injection
8) By Folic Acid: Folic Acid Supplements (Oral); Injectable Folic Acid
9) By Hydroxychloroquine: Hydroxychloroquine Tablets (Oral); Hydroxychloroquine Injectable Formulation
10) By Chloroquine: Chloroquine Tablets (Oral); Chloroquine Injectable Formulation
Companies Mentioned: Pfizer Inc; Merck & Co Inc; AbbVie Inc.; Sanofi S.A.; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r31481

1. Executive Summary

2. Veterinary Autoimmune Disease Therapeutics Market Characteristics

3. Veterinary Autoimmune Disease Therapeutics Market Trends And Strategies

4. Veterinary Autoimmune Disease Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Veterinary Autoimmune Disease Therapeutics Growth Analysis And Strategic Analysis Framework

5.1. Global Veterinary Autoimmune Disease Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Veterinary Autoimmune Disease Therapeutics Market Growth Rate Analysis
5.4. Global Veterinary Autoimmune Disease Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Veterinary Autoimmune Disease Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Veterinary Autoimmune Disease Therapeutics Total Addressable Market (TAM)

6. Veterinary Autoimmune Disease Therapeutics Market Segmentation

6.1. Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Corticosteroids
Azathioprine
Cyclosporine
Mycophenolate
Leflunomide
Cyclophosphamide
Levothyroxine
Folic Acid
Hydroxychloroquine
Chloroquine
6.2. Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Companion Animals
Livestock Animals
Other Animals
6.3. Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hypothyroidism
Pemphigus Disease
Canine Lupus
Auto-Immune Hemolytic Anemia
Bullous Pemphigoid
Discoid Lupus Erythematosus (DLE)
Immune-Related Arthritis
Other Diseases
6.4. Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Veterinary Hospitals
Veterinary Clinics
6.5. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prednisone
Prednisolone
Dexamethasone
Methylprednisolone
Triamcinolone
6.6. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Azathioprine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Azathioprine Oral Tablets
Azathioprine Injectable Formulation
6.7. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Cyclosporine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Cyclosporine (Atopica)
Injectable Cyclosporine
6.8. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Mycophenolate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mycophenolate Mofetil (Oral Form)
Mycophenolate Sodium (Injectable Form)
6.9. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Leflunomide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Leflunomide Tablets (Oral)
Leflunomide Injection
6.10. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Cyclophosphamide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Cyclophosphamide
Injectable Cyclophosphamide
6.11. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Levothyroxine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Levothyroxine Sodium Tablets (Oral)
Levothyroxine Sodium Injection
6.12. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Folic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Folic Acid Supplements (Oral)
Injectable Folic Acid
6.13. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Hydroxychloroquine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hydroxychloroquine Tablets (Oral)
Hydroxychloroquine Injectable Formulation
6.14. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Chloroquine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chloroquine Tablets (Oral)
Chloroquine Injectable Formulation

7. Veterinary Autoimmune Disease Therapeutics Market Regional And Country Analysis

7.1. Global Veterinary Autoimmune Disease Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Veterinary Autoimmune Disease Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Veterinary Autoimmune Disease Therapeutics Market

8.1. Asia-Pacific Veterinary Autoimmune Disease Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Veterinary Autoimmune Disease Therapeutics Market

9.1. China Veterinary Autoimmune Disease Therapeutics Market Overview
9.2. China Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Veterinary Autoimmune Disease Therapeutics Market

10.1. India Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Veterinary Autoimmune Disease Therapeutics Market

11.1. Japan Veterinary Autoimmune Disease Therapeutics Market Overview
11.2. Japan Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Veterinary Autoimmune Disease Therapeutics Market

12.1. Australia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Veterinary Autoimmune Disease Therapeutics Market

13.1. Indonesia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Veterinary Autoimmune Disease Therapeutics Market

14.1. South Korea Veterinary Autoimmune Disease Therapeutics Market Overview
14.2. South Korea Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Veterinary Autoimmune Disease Therapeutics Market

15.1. Western Europe Veterinary Autoimmune Disease Therapeutics Market Overview
15.2. Western Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Veterinary Autoimmune Disease Therapeutics Market

16.1. UK Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Veterinary Autoimmune Disease Therapeutics Market

17.1. Germany Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Veterinary Autoimmune Disease Therapeutics Market

18.1. France Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Veterinary Autoimmune Disease Therapeutics Market

19.1. Italy Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Veterinary Autoimmune Disease Therapeutics Market

20.1. Spain Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Veterinary Autoimmune Disease Therapeutics Market

21.1. Eastern Europe Veterinary Autoimmune Disease Therapeutics Market Overview
21.2. Eastern Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Veterinary Autoimmune Disease Therapeutics Market

22.1. Russia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Veterinary Autoimmune Disease Therapeutics Market

23.1. North America Veterinary Autoimmune Disease Therapeutics Market Overview
23.2. North America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Veterinary Autoimmune Disease Therapeutics Market

24.1. USA Veterinary Autoimmune Disease Therapeutics Market Overview
24.2. USA Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Veterinary Autoimmune Disease Therapeutics Market

25.1. Canada Veterinary Autoimmune Disease Therapeutics Market Overview
25.2. Canada Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Veterinary Autoimmune Disease Therapeutics Market

26.1. South America Veterinary Autoimmune Disease Therapeutics Market Overview
26.2. South America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Veterinary Autoimmune Disease Therapeutics Market

27.1. Brazil Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Veterinary Autoimmune Disease Therapeutics Market

28.1. Middle East Veterinary Autoimmune Disease Therapeutics Market Overview
28.2. Middle East Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Veterinary Autoimmune Disease Therapeutics Market

29.1. Africa Veterinary Autoimmune Disease Therapeutics Market Overview
29.2. Africa Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Veterinary Autoimmune Disease Therapeutics Market Competitive Landscape And Company Profiles

30.1. Veterinary Autoimmune Disease Therapeutics Market Competitive Landscape
30.2. Veterinary Autoimmune Disease Therapeutics Market Company Profiles
- 30.2.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Veterinary Autoimmune Disease Therapeutics Market Other Major And Innovative Companies

31.1. GlaxoSmithKline
31.2. Takeda Pharmaceutical Company
31.3. Amgen Inc.
31.4. Teva Pharmaceuticals Industries Ltd.
31.5. Zoetis Inc
31.6. Boehringer Ingelheim International GmbH
31.7. Sumitomo Pharma Co. Ltd.
31.8. IDEXX Laboratories Inc.
31.9. Cipla Inc.
31.10. Mallinckrodt Pharmaceuticals
31.11. Virbac S.A
31.12. Dechra Pharmaceuticals plc
31.13. Neogen Corporation
31.14. Vetoquinol S.A.
31.15. Norbrook Laboratories Limited

32. Global Veterinary Autoimmune Disease Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Autoimmune Disease Therapeutics Market

34. Recent Developments In The Veterinary Autoimmune Disease Therapeutics Market

35. Veterinary Autoimmune Disease Therapeutics Market High Potential Countries, Segments and Strategies

35.1 Veterinary Autoimmune Disease Therapeutics Market In 2029 - Countries Offering Most New Opportunities
35.2 Veterinary Autoimmune Disease Therapeutics Market In 2029 - Segments Offering Most New Opportunities
35.3 Veterinary Autoimmune Disease Therapeutics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer